Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Tryptophan and N-Methyl-3,4-Methylenedioxyamphetamine

Research Papers that Mention the Interaction

At typical doses for each of these compounds, neurochemical studies suggest a continuum of serotonergic enhancement from tryptophan through the SSRIs, fenfluramine and MDMA having the largest effect.
Biological Psychiatry  •  2010  |  View Paper
Following MDMA administration, the same dose of tryptophan caused a smaller (26%) rise in brain serotonin whereas in blood it had no effect.
Journal of psychopharmacology  •  2013  |  View Paper
Tryptophan modulated effects of several drugs on neuronal firing rates, including a selective 5-HT(1A) receptor antagonist (WAY-100635), a monoamine oxidase inhibitor (pargyline), a selective serotonin reuptake inhibitor (fluoxetine), and a serotonin-releasing agent ( methylenedioxymethamphetamine).
European journal of pharmacology  •  2008  |  View Paper
Brain tryptophan hydroxylase activity decreases within 15 min after a single administration of 3,4-methylenedioxymethamphetamine.
European journal of pharmacology  •  1995  |  View Paper
Based upon IC50 values, L-tryptophan increased the potency of MDMA by approximately 3-fold.
Pretreatment with L-tryptophan (100 microM) lowered the doses of MDMA required to inhibit unit activity.
The question is raised as to what effect L-tryptophan may have on the psychotropic and neurotoxic actions of MDMA.
European journal of pharmacology  •  1990  |  View Paper
These studies suggest that MDMA and its congeners inactivate central tryptophan hydroxylase by inducing oxidation of key enzyme sulfhydryl groups.
Journal of neurochemistry  •  1989  |  View Paper
Decreases in mouse central tryptophan hydroxylase activity, and prolonged decreases in mouse 5-hydroxyindole concentrations, were observed only after multiple doses of MDMA , suggesting that the duration of exposure may be an important determinant of toxic effects.
These results are in contrast to effects in rats, in which a single 10 mg/kg dose of MDMA induced immediate and prolonged decreases in both central tryptophan hydroxylase activity and 5-hydroxyindole concentrations.
Neuropharmacology  •  1987  |  View Paper